Free Trial

CERo Therapeutics (CERO) Short Interest Ratio & Short Volume

CERo Therapeutics logo
$9.36 -0.10 (-1.06%)
Closing price 07/3/2025 03:44 PM Eastern
Extended Trading
$9.28 -0.07 (-0.80%)
As of 07/3/2025 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CERo Therapeutics Short Interest Data

CERo Therapeutics (CERO) has a short interest of 38,000 shares, representing 10.46% of the float (the number of shares available for trading by the public). This marks a -94.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 309,350 shares to cover all short positions.

Current Short Interest
38,000 shares
Previous Short Interest
640,700 shares
Change Vs. Previous Month
-94.07%
Dollar Volume Sold Short
$277.78 thousand
Short Interest Ratio
0.0 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
390,000 shares
Float Size
363,400 shares
Short Percent of Float
10.46%
Today's Trading Volume
56,771 shares
Average Trading Volume
309,350 shares
Today's Volume Vs. Average
18%
Short Selling CERo Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for CERo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CERO Short Interest Over Time

CERO Days to Cover Over Time

CERO Percentage of Float Shorted Over Time

CERo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202538,000 shares $277.78 thousand -94.1%10.5%0 $7.31
5/31/2025640,700 shares $283.32 thousand -1.5%11.8%0.3 $0.44
5/15/2025650,700 shares $379.81 thousand -36.2%12.0%0.4 $0.58
4/30/20251,020,000 shares $907.70 thousand +229.8%26.8%0.6 $0.89
4/15/2025309,300 shares $180.94 thousand -9.6%8.1%0.2 $0.59
3/31/2025342,200 shares $249.81 thousand -59.4%14.0%0.4 $0.73
3/15/2025843,600 shares $860.47 thousand +188.2%34.6%1.2 $1.02
2/28/2025292,700 shares $488.81 thousand -11.6%12.4%0.5 $1.67
2/15/2025331,000 shares $681.86 thousand -42.2%28.1%0.5 $2.06
1/31/2025572,600 shares $1.23 million +264.5%55.1%0.5 $2.14
1/15/2025157,100 shares $405.32 thousand +4.7%15.1%0.2 $2.58
12/31/2024150,000 shares $900 thousand -98.0%16.5%0.2 $6.00
12/15/20247,300,000 shares $413.91 thousand +25.2%9.4%0.1 $0.06
11/30/20245,830,000 shares $1.13 million -25.8%7.6%0.1 $0.19
11/15/20247,860,000 shares $2.24 million +391.3%30.0%0.1 $0.29
10/31/20241,600,000 shares $137.28 thousand +262.4%3.9%0.1 $0.09
10/15/2024441,500 shares $42.83 thousand -81.0%1.1%0 $0.10
9/30/20242,320,000 shares $216.46 thousand +771.2%10.2%0.2 $0.09
9/15/2024266,300 shares $24.82 thousand -59.1%0.6%0 $0.09
8/31/2024651,500 shares $82.87 thousand -41.3%1.5%0.1 $0.13
8/15/20241,110,000 shares $164.28 thousand -25.5%3.6%0.2 $0.15
7/31/20241,490,000 shares $232.44 thousand +15.5%15.4%0.3 $0.16
7/15/20241,290,000 shares $249.23 thousand No Change13.4%0.5 $0.19

CERO Short Interest - Frequently Asked Questions

What is CERo Therapeutics' current short interest?

Short interest is the volume of CERo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 38,000 shares of CERO short. 10.46% of CERo Therapeutics' shares are currently sold short. Learn More on CERo Therapeutics' current short interest.

What is a good short interest percentage for CERo Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.46% of CERo Therapeutics' floating shares are currently sold short.

Is CERo Therapeutics' short interest increasing or decreasing?

CERo Therapeutics saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 38,000 shares, a decrease of 94.1% from the previous total of 640,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is CERo Therapeutics' float size?

CERo Therapeutics currently has issued a total of 390,000 shares. Some of CERo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CERo Therapeutics currently has a public float of 363,400 shares.

How does CERo Therapeutics' short interest compare to its competitors?

10.46% of CERo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CERo Therapeutics: Acurx Pharmaceuticals, Inc. (2.59%), Ernexa Therapeutics Inc. (1.65%), ProPhase Labs, Inc. (0.47%), Edesa Biotech, Inc. (0.54%), Synlogic, Inc. (0.53%), UNITY Biotechnology, Inc. (3.65%), Citius Pharmaceuticals, Inc. (12.82%), GeoVax Labs Inc. (3.59%), TherapeuticsMD, Inc. (0.37%), 23andMe Holding Co. (11.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short CERo Therapeutics stock?

Short selling CERO is an investing strategy that aims to generate trading profit from CERo Therapeutics as its price is falling. CERO shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CERo Therapeutics?

A short squeeze for CERo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CERO, which in turn drives the price of the stock up even further.

How often is CERo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CERO, twice per month. The most recent reporting period available is June, 15 2025.




This page (NASDAQ:CERO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners